salicylic acid has been researched along with beta-resorcylic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howard, SM; Scherrer, RA | 1 |
| Günzler, V; Hanauske-Abel, HM; Kivirikko, KI; Majamaa, K; Myllylä, R | 1 |
| Björnberg, O; Jensen, KF; Palfey, BA | 1 |
| Bartyzel, P; Bradbury, BJ; Gaumond, BR; Kaufman, TS; Marsh, HC; Nieto, MJ; Scesney, SM; Sindelar, RD | 1 |
| Jiang, L; Luo, WC; Xiao, T; Xie, XY; Xue, CB; Zhang, L | 1 |
| Chesson, A; Duthie, GG; Russell, WR; Scobbie, L | 1 |
| Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
| Brem, J; Cain, R; Fishwick, CW; Owens, RJ; Rydzik, AM; Salimraj, R; Schofield, CJ; Spencer, J; van Berkel, SS; Verma, A | 1 |
| Hanfeld, V; Wagner, G | 1 |
| Bulte, JWM; He, X; Janowski, M; McMahon, MT; Pearl, M; Pomper, MG; Song, X; Walczak, P; Yang, X | 1 |
| Acuña-Castroviejo, D; Bakkali, M; Barriocanal-Casado, E; Díaz-Casado, ME; Duarte, J; Escames, G; Hidalgo-Gutiérrez, A; López, LC; Prehn, C; Romero, M; Sánchez-Maldonado, L; Sayed, RK | 1 |
| Caboni, M; D'Onofrio, A; Ghiglieri, M; Khoo, C; Lewis, K; Liu, H; Morrissette, M; O'Connor, K; Strandwitz, P | 1 |
12 other study(ies) available for salicylic acid and beta-resorcylic acid
| Article | Year |
|---|---|
Use of distribution coefficients in quantitative structure-activity relationships.
Topics: Animals; Biological Transport, Active; Cell Membrane Permeability; Colon; Hydrogen-Ion Concentration; Intestinal Absorption; Lipid Metabolism; Oxidative Phosphorylation Coupling Factors; Rats; Regression Analysis; Structure-Activity Relationship | 1977 |
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.
Topics: Animals; Ascorbic Acid; Binding Sites; Chick Embryo; Ketoglutaric Acids; Kinetics; Phenols; Procollagen-Proline Dioxygenase; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 1986 |
Specific inhibition of a family 1A dihydroorotate dehydrogenase by benzoate pyrimidine analogues.
Topics: Benzoates; Dihydroorotate Oxidase; Enzyme Inhibitors; Ligands; Pyrimidines; Structure-Activity Relationship; Trypanocidal Agents | 2001 |
Synthesis and complement inhibitory activity of B/C/D-ring analogues of the fungal metabolite 6,7-diformyl-3',4',4a',5',6',7',8',8a'-octahydro-4,6',7'-trihydroxy- 2',5',5',8a'-tetramethylspiro[1'(2'H)-naphthalene-2(3H)-benzofuran].
Topics: Animals; Complement C3a; Complement C5a; Hemolysis; Humans; In Vitro Techniques; Rabbits; Sesquiterpenes; Structure-Activity Relationship | 2003 |
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
Topics: Benzaldehydes; Benzoic Acid; Enzyme Inhibitors; Hydrogen Bonding; Models, Molecular; Monophenol Monooxygenase; Quantitative Structure-Activity Relationship; Thiosemicarbazones | 2007 |
Inhibition of 15-lipoxygenase-catalysed oxygenation of arachidonic acid by substituted benzoic acids.
Topics: Arachidonate 15-Lipoxygenase; Arachidonic Acid; Benzoates; Catalysis; Colon; Enzyme Inhibitors; Humans; Lipoxygenase Inhibitors; Oxidation-Reduction; Oxygen; Structure-Activity Relationship | 2008 |
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
Assay platform for clinically relevant metallo-β-lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metals | 2013 |
[Synthesis of phenol-antigen conjugates by reacting N-hydroxysuccinimidic esters of hydroxybenzoic acids with human serum albumin and bovine gamma globulin].
Topics: Acetylation; Animals; Antigens; Cattle; gamma-Globulins; Gentisates; Humans; Hydroxybenzoates; Phenols; Salicylates; Salicylic Acid; Serum Albumin; Succinimides | 1982 |
Salicylic acid analogues as chemical exchange saturation transfer MRI contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Hydroxybenzoates; Infusions, Intra-Arterial; Magnetic Resonance Imaging, Interventional; Osmolar Concentration; Perfusion; Perfusion Imaging; Phthalic Acids; Rats, Sprague-Dawley; Salicylic Acid; Sodium Salicylate; Solutions | 2016 |
β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in
Topics: Animals; Brain; Disease Models, Animal; Energy Metabolism; Histocytochemistry; Hydroxybenzoates; Mice; Mitochondrial Encephalomyopathies; Neuroprotective Agents; Salicylic Acid; Survival Analysis; Treatment Outcome; Ubiquinone | 2019 |
Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model.
Topics: Bacteroidaceae; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Humans; Hydroxybenzoates; Microbial Sensitivity Tests; Models, Biological; Plant Extracts; Powders; Salicylic Acid; Urinary Tract Infections; Vaccinium macrocarpon | 2019 |